A Common Deletion in the APOBEC3 Genes and Breast Cancer Risk

Authors:
  • RDRyan J. Delahanty
    Ryan J. Delahanty
  • GLGuoliang Li
    Guoliang Li
  • YGYu-Tang Gao
    Yu-Tang Gao
  • WLWei Lu
    Wei Lu
  • QCQiuyin Cai
    Qiuyin Cai
  • YXYong-Bing Xiang
    Yong-Bing Xiang
  • BJBu-Tian Ji
    Bu-Tian Ji
  • YZYing Zheng
    Ying Zheng
  • SASimak Ali
    Simak Ali
  • XSXiao-Ou Shu
    Xiao-Ou Shu

Abstract
Genome-wide association studies (GWASs) have identified multiple genetic susceptibility loci for breast cancer. However, these loci explain only a small fraction of the heritability. Very few studies have evaluated copy number variation (CNV), another important source of human genetic variation, in relation to breast cancer risk. We conducted a CNV GWAS in 2623 breast cancer patients and 1946 control subjects using data from Affymetrix SNP Array 6.0 (stage 1). We then replicated the most promising CNV using real-time quantitative polymerase chain reaction (qPCR) in an independent set of 4254 case patients and 4387 control subjects (stage 2). All subjects were recruited from population-based studies conducted among Chinese women in Shanghai. Of the 268 common CNVs (minor allele frequency ≥ 5%) investigated in stage 1, the strongest association was found for a common deletion in the APOBEC3 genes (P = 1.1×10−4) and was replicated in stage 2 (odds ratio =1.35, 95% confidence interval [CI] = 1.27 to 1.44; P = 9.6×10−22). Analyses of all samples from both stages using qPCR data produced odds ratios of 1.31 (95% CI = 1.21 to 1.42) for a one-copy deletion and 1.76 (95% CI = 1.57 to 1.97) for a two-copy deletion (P = 2.0×10−24). We provide convincing evidence for a novel breast cancer locus at the APOBEC3 genes. This CNV is one of the strongest common genetic risk variants identified so far for breast cancer.

This publication has 41 references indexed in Scilit: